Quidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses
May 16, 2017 17:15 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - May 16, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Clostridium difficile (C. difficile) Infections
May 11, 2017 14:30 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - May 11, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
May 01, 2017 17:30 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - May 01, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Reports First Quarter 2017 Financial Results
April 24, 2017 16:10 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - April 24, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Hold First Quarter 2017 Financial Results Conference Call on April 24, 2017
April 11, 2017 19:00 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - April 11, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Present at the Barclays Global Healthcare Conference
March 02, 2017 18:00 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - March 02, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Reports Fourth Quarter and Full Year 2016 Financial Results
February 08, 2017 16:10 ET
|
Quidel
SAN DIEGO, CA --(Marketwired - February 08, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic...
Quidel to Hold Fourth Quarter and Full Year 2016 Financial Results Conference Call on February 8, 2017
January 25, 2017 16:30 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - January 25, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Announces Modification of Revenue Reporting Categories
January 23, 2017 19:00 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - January 23, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel Announces Preliminary Revenue for Fourth Quarter 2016
January 06, 2017 16:10 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - January 06, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...